Moul JW, Douglas TH, McCarthy WF, McLeod DG. 1996. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 155(5):1667–1673.
Mullan F. 1985. Seasons of survival: Reflections of a physician with cancer. New England Journal of Medicine 313(4):270–273.
NCCS (National Coalition for Cancer Survivorship). 1996. Imperatives for Quality Cancer Care: Access, Advocacy, Action, and Accountability. Clark EJ, Stovall EL, Leigh S, Siu AL, Austin DK, Rowland JH. Silver Spring, MD: NCCS.
NCI (National Cancer Institute). 2004a. About SEER. [Online]. Available: http://seer.cancer.gov/about/ [accessed December 13, 2004].
NCI. 2004b. About Survivorship Research: Survivorship Definitions. [Online]. Available: http://dccps.nci.nih.gov/ocs/definitions.html [accessed April 9, 2004].
NCI. 2004c. Cancer Progress Report—2003 Update. [Online]. Available: http://progressreport.cancer.gov/index.asp [accessed May 31, 2004].
NCI. 2004d. Relative Survival. [Online]. Available: http://seer.cancer.gov/seerstat/WebHelp/Relative_Survival.htm [accessed May 10, 2004].
NCI. 2005a. Cancer Control Continuum. [Online]. Available: http://cancercontrol.cancer.gov/od/continuum.html [accessed April 19, 2005].
NCI. 2005b. Cancer Query System: Cancer Prevalence Database. [Online]. Available: http://srab.cancer.gov/prevalence/canques.html [accessed June 2, 2005].
NCI. 2005c. Estimated U.S. Cancer Prevalence. [Online]. Available: http://cancercontrol.cancer.gov/ocs/prevalence/prevalence.html [accessed May 31, 2005].
Ostir GV, Carlson JE, Black SA, Rudkin L, Goodwin JS, Markides KS. 1999. Disability in older adults. Prevalence, causes, and consequences. Behav Med 24(4):147–156.
Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. 2004. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291(20):2441–2447.
Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW. 2004. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer 100(12):2533–2542.
President’s Cancer Panel. 2004a. Living Beyond Cancer: A European Dialogue. Bethesda, MD: National Cancer Institute.
President’s Cancer Panel. 2004b. Living Beyond Cancer: Finding a New Balance. Bethesda, MD: National Cancer Institute.
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK, eds. 2004. SEER Cancer Statistics Review, 1975–2001. Bethesda, MD: National Cancer Institute. [Online]. Available: http://seer.cancer.gov/csr/1975_2001/ [accessed April 29, 2004].
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK, eds. 2005. SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute. [Online]. Available: http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission [accessed June 7, 2005].
Rowland J, Mariotto A, Aziz N, Tesauro G, Feuer EJ, Blackman D, Thompson P, Pollock LA. 2004. Cancer survivorship—United States, 1971–2001. MMWR 53(24):526–529.
Shavers VL, Brown ML. 2002. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357.
Singh GK, Miller BA, Hankey BF, Edwards BK. 2003. Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. NCI Cancer Surveillance Monograph Series, No. 4. Bethesda, MD: National Cancer Institute.
Steenland K, Rodriguez C, Mondul A, Calle EE, Thun M. 2004. Prostate cancer incidence and survival in relation to education (United States). Cancer Causes Control 15(9):939–945.